1. Home
  2. WTTR vs HRMY Comparison

WTTR vs HRMY Comparison

Compare WTTR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTTR

Select Water Solutions Inc.

HOLD

Current Price

$18.91

Market Cap

2.1B

Sector

Energy

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$34.46

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTTR
HRMY
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
WTTR
HRMY
Price
$18.91
$34.46
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$16.67
$44.11
AVG Volume (30 Days)
1.4M
709.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
7.97
EPS
N/A
0.55
Revenue
$1,528,930,000.00
$868,453,000.00
Revenue This Year
$2.11
$19.75
Revenue Next Year
$4.94
$12.88
P/E Ratio
$69.16
$64.00
Revenue Growth
120.79
21.51
52 Week Low
$7.86
$25.52
52 Week High
$20.48
$40.87

Technical Indicators

Market Signals
Indicator
WTTR
HRMY
Relative Strength Index (RSI) 56.66 62.32
Support Level $17.82 $25.92
Resistance Level $19.39 $34.99
Average True Range (ATR) 0.66 1.10
MACD -0.13 0.39
Stochastic Oscillator 55.73 75.30

Price Performance

Historical Comparison
WTTR
HRMY

About WTTR Select Water Solutions Inc.

Select Water Solutions Inc provides sustainable water-management solutions to the energy industry in the United States. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. The company's reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates maximum revenue from the Water Services segment, which comprises its short-cycle, field-based service offerings, including water transfer, water sourcing, fluids hauling, monitoring, containment, water-network automation, and the services associated with Peak Rentals. This segment earns revenue via market-based day rates, time-and-materials, or per-barrel delivered under MSAs and short-term work orders.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: